These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8429921)

  • 1. Examination of the involvement of neuropeptide Y (NPY) in cerebral autoregulation using the novel NPY antagonist PP56.
    Goadsby PJ; Edvinsson L
    Neuropeptides; 1993 Jan; 24(1):27-33. PubMed ID: 8429921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic effect of D-myo-inositol-1,2,6-trisphosphate (PP56) on neuropeptide Y-induced vasoconstriction in the feline dental pulp.
    Kim SK; Ang L; Hsu YY; Dörscher-Kim J; Kim S
    Arch Oral Biol; 1996; 41(8-9):791-8. PubMed ID: 9022916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of increasing doses of alpha-trinositol on cerebral blood flow autoregulation.
    Vraamark T; Waldemar G; Edvinsson L; Paulson OB
    Pharmacol Toxicol; 1997 Jan; 80(1):38-43. PubMed ID: 9148281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog.
    Potter EK; Edvinsson L; Gustafsson T
    Eur J Pharmacol; 1992 Oct; 221(2-3):307-14. PubMed ID: 1426007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
    Sun XY; Dahlöf C; Edvinsson L; Hedner T
    Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
    Sun XY; Edvinsson L; Hedner T
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
    Schwieler JH; Hjemdahl P
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding.
    Heilig M; Edvinsson L; Wahlestedt C
    Eur J Pharmacol; 1991 Dec; 209(1-2):27-32. PubMed ID: 1667639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic thyroidal vasoconstriction is not blocked by a neuropeptide Y antagonist or antiserum.
    Dey M; Michalkiewicz M; Huffman L; Hedge GA
    Peptides; 1993; 14(6):1179-86. PubMed ID: 8134299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries.
    Edvinsson L; Adamsson M; Jansen I
    Neuropeptides; 1990 Oct; 17(2):99-105. PubMed ID: 2280824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
    Pernow J; Modin A; Lundberg JM
    Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of D-myo-inositol-1,2,6-trisphosphate on glucose-stimulated insulin secretion in the mouse.
    Ahrén B
    Neuropeptides; 1992 Mar; 21(3):163-6. PubMed ID: 1630602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuropeptide Y on canine cerebral circulation.
    Suzuki Y; Shibuya M; Ikegaki I; Satoh S; Takayasu M; Asano T
    Eur J Pharmacol; 1988 Feb; 146(2-3):271-7. PubMed ID: 3371399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
    Adamsson M; Fallgren B; Edvinsson L
    Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hypercarbia increases the lower limit of cerebral blood flow autoregulation in a porcine model.
    Nusbaum DM; Brady KM; Kibler KK; Blaine Easley R
    Neurol Res; 2016 Mar; 38(3):196-204. PubMed ID: 26311295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling?
    Bell D; McDermott BJ
    Gen Pharmacol; 1998 Nov; 31(5):689-96. PubMed ID: 9809464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of neuropeptide Y-induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol-1.2.6-trisphosphate (PP56) in rabbit femoral arteries.
    Adamsson M; Edvinsson L
    Neuropeptides; 1991 May; 19(1):13-6. PubMed ID: 1891070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Sun X; Edvinsson L; Hedner T
    J Hypertens; 1993 Sep; 11(9):935-43. PubMed ID: 8254175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.